Dermtech Inc.
LA JOLLA, California, February 7, 2011 - DermTech International, Inc., a biotechnology company dedicated to
bringing genomic medicine to dermatologists, today announced that the
discovery data on its new genomic assay for melanoma have been published in
the British Journal of Dermatology.
